StockData
BioAge Labs, Inc. logo

BioAge Labs, Inc. (BIOA) SEC filings

BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$5.55−0.10 (-1.77%)

Close on Nov 13, 2026Market cap $254.73MP/E –Yield –

SEC filings

29 of BioAge Labs's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 5, 2026SEC EDGAR
Current report8-KNov 5, 2026Nov 5, 2026SEC EDGAR
Current report8-KOct 2, 2026Oct 2, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 5, 2026SEC EDGAR
Current report8-KAug 5, 2026Aug 5, 2026SEC EDGAR
Current report8-KJun 10, 2026Jun 12, 2026SEC EDGAR
Current report8-KMay 8, 2026May 8, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 8, 2026SEC EDGAR
Proxy statementDEF 14AJun 10, 2026Apr 21, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 24, 2026SEC EDGAR
Current report8-KMar 24, 2026Mar 24, 2026SEC EDGAR
Current report8-KJan 21, 2026Jan 22, 2026SEC EDGAR
Current report8-KJan 20, 2026Jan 20, 2026SEC EDGAR
Current report8-KJan 12, 2026Jan 12, 2026SEC EDGAR
Current report8-KDec 4, 2025Dec 4, 2025SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 6, 2025SEC EDGAR
Current report8-KNov 6, 2025Nov 6, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 6, 2025SEC EDGAR
Current report8-KAug 6, 2025Aug 6, 2025SEC EDGAR
Current report8-KJun 5, 2025Jun 9, 2025SEC EDGAR
Current report8-KJun 4, 2025Jun 4, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 6, 2025SEC EDGAR
Current report8-KMay 6, 2025May 6, 2025SEC EDGAR
Proxy statementDEF 14AJun 5, 2025Apr 17, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 20, 2025SEC EDGAR
Current report8-KMar 20, 2025Mar 20, 2025SEC EDGAR
Quarterly report10-QSep 30, 2024Nov 7, 2024SEC EDGAR
Current report8-KNov 7, 2024Nov 7, 2024SEC EDGAR
Current report8-KSep 25, 2024Sep 27, 2024SEC EDGAR

See a number that looks wrong?